Bridgeway Capital Management’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,000
| Closed | -$79.5K | – | 1364 |
|
|
2023
Q2 | $79.5K | Buy |
+5,000
| New | +$79.5K | ﹤0.01% | 1287 |
|
|
2022
Q4 | – | Sell |
-29,900
| Closed | -$284K | – | 1367 |
|
|
2022
Q3 | $284K | Buy |
29,900
+5,700
| +24% | +$54.1K | 0.01% | 1060 |
|
|
2022
Q2 | $290K | Hold |
24,200
| – | – | 0.01% | 1001 |
|
|
2022
Q1 | $317K | Buy |
+24,200
| New | +$317K | 0.01% | 1057 |
|
|
2019
Q2 | – | Sell |
-22,360
| Closed | -$1.17M | – | 1306 |
|
|
2019
Q1 | $1.17M | Buy |
22,360
+3,440
| +18% | +$180K | 0.01% | 701 |
|
|
2018
Q4 | $596K | Hold |
18,920
| – | – | 0.01% | 939 |
|
|
2018
Q3 | $1.15M | Hold |
18,920
| – | – | 0.01% | 831 |
|
|
2018
Q2 | $1M | Hold |
18,920
| – | – | 0.01% | 877 |
|
|
2018
Q1 | $1.1M | Buy |
18,920
+530
| +3% | +$30.7K | 0.01% | 815 |
|
|
2017
Q4 | $644K | Hold |
18,390
| – | – | 0.01% | 1010 |
|
|
2017
Q3 | $671K | Hold |
18,390
| – | – | 0.01% | 995 |
|
|
2017
Q2 | $460K | Hold |
18,390
| – | – | 0.01% | 1110 |
|
|
2017
Q1 | $497K | Sell |
18,390
-17,950
| -49% | -$485K | 0.01% | 1076 |
|
|
2016
Q4 | $1.05M | Buy |
36,340
+2,310
| +7% | +$67K | 0.01% | 803 |
|
|
2016
Q3 | $1.4M | Buy |
34,030
+20,126
| +145% | +$827K | 0.02% | 667 |
|
|
2016
Q2 | $439K | Sell |
13,904
-8,546
| -38% | -$270K | 0.01% | 1098 |
|
|
2016
Q1 | $1.16M | Buy |
22,450
+3,020
| +16% | +$156K | 0.02% | 703 |
|
|
2015
Q4 | $1.85M | Buy |
19,430
+13,620
| +234% | +$1.3M | 0.03% | 516 |
|
|
2015
Q3 | $479K | Buy |
+5,810
| New | +$479K | 0.01% | 1054 |
|